[Aganon in the treatment of patients with allergic rhinosinusopathies].
D000293:Adolescent; D000328:Adult; D002648:Child; D004123:Dimethylamines / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006571:Heterocyclic Compounds / Q000627:therapeutic use*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010256:Paranasal Sinuses; D010793:Phthalazines; D011724:Pyridazines / Q000627:therapeutic use*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*; D012852:Sinusitis / Q000188:drug therapy*
D004123:Dimethylamines; D006571:Heterocyclic Compounds; D006634:Histamine H1 Antagonists; D010793:Phthalazines; D011724:Pyridazines; C009376:talastine
Aganon v lechenii bol'nykh allergicheskoi rinosinusopatieĭ.